racemic albuterol MDI

DRUG2 trials

Sponsors

Sumitomo Pharma America, Inc.

Conditions

Asthma

Phase 3

Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma

CompletedNCT00073814

Sumitomo Pharma America, Inc.Asthma

Start: 2002-12-31End: 2003-06-30Updated: 2012-02-22

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

CompletedNCT00073827

Sumitomo Pharma America, Inc.Asthma

Start: 2002-05-31End: 2003-01-31Updated: 2012-02-22